Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network
Year: 2003
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Institutions: WellStar Health System, Sarah Cannon, Tennessee Oncology
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1978235999
